ResearcherGerman Cancer Research CenterNo recent work listed
Lina Jansen
Matched on ORCID iD 0000-0001-8004-4940; OpenAlex author ID A5088323634. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 5, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2016: 1 paper · 2017: none · 2018: 3 papers · 2019: 2 papers · 2020: none · 2021: 1 paper
Papers 7
- Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic Cancer-More is Better? A Large Internat… First author DOI 10.1097/sla.0000000000003558↗
- Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations. First author DOI 10.1136/gutjnl-2017-314828↗
- Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a … Last author DOI 10.1186/s12916-019-1304-y↗
- Nonsurgical therapies for resected and unresected pancreatic cancer in Europe and USA in 2003-2014: a large international population-based study. First author DOI 10.1002/ijc.31628↗
- Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international populati… First author DOI 10.1186/s12916-018-1120-9↗
- Comparative performance of a modified landmark approach when no time of treatment data are available within oncological databases: exemplary cohort study among… First author DOI 10.2147/clep.s160973↗
- Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States. Co-author DOI 10.1097/mpa.0000000000000588↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hermann Brenner · 7 shared papers, 2016–2021 · strength 0.54
- Paper Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic… DOI 10.1097/sla.0000000000003558↗
- Paper Comparative performance of a modified landmark approach when no time of treatment data are available within oncological… DOI 10.2147/clep.s160973↗
- Paper Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and re… DOI 10.1186/s12916-019-1304-y↗
- Lydia G. van der Geest · 6 shared papers, 2018–2021 · strength 0.49
- Paper Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic… DOI 10.1097/sla.0000000000003558↗
- Paper Comparative performance of a modified landmark approach when no time of treatment data are available within oncological… DOI 10.2147/clep.s160973↗
- Paper Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and re… DOI 10.1186/s12916-019-1304-y↗
- V.E.P.P. Lemmens · 5 shared papers, 2018–2021 · strength 0.40
- Paper Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic… DOI 10.1097/sla.0000000000003558↗
- Paper Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and re… DOI 10.1186/s12916-019-1304-y↗
- Paper Nonsurgical therapies for resected and unresected pancreatic cancer in Europe and USA in 2003-2014: a large internation… DOI 10.1002/ijc.31628↗
- Lei Huang · 5 shared papers, 2018–2021 · strength 0.40
- Paper Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic… DOI 10.1097/sla.0000000000003558↗
- Paper Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and re… DOI 10.1186/s12916-019-1304-y↗
- Paper Nonsurgical therapies for resected and unresected pancreatic cancer in Europe and USA in 2003-2014: a large internation… DOI 10.1002/ijc.31628↗
- Marc G. Besselink · 4 shared papers, 2018–2021 · strength 0.33
- Paper Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic… DOI 10.1097/sla.0000000000003558↗
- Paper Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and re… DOI 10.1186/s12916-019-1304-y↗
- Paper Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first … DOI 10.1186/s12916-018-1120-9↗
- Robert Grützmann · 3 shared papers, 2019–2021 · strength 0.26
- Paper Significance of Examined Lymph Node Number in Accurate Staging and Long-term Survival in Resected Stage I-II Pancreatic… DOI 10.1097/sla.0000000000003558↗
- Paper Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and re… DOI 10.1186/s12916-019-1304-y↗
- Paper Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations. DOI 10.1136/gutjnl-2017-314828↗
- Bas Groot Koerkamp · 1 shared paper, 2021 · strength 0.12
- Hjalmar C. van Santvoort · 1 shared paper, 2021 · strength 0.12
- Pauline A. J. Vissers · 1 shared paper, 2018 · strength 0.09
- Janick G. Weberpals · 1 shared paper, 2018 · strength 0.09
- Esther Molina‐Montes · 1 shared paper, 2019 · strength 0.06
- Markus Wolfgang Büchler · 1 shared paper, 2019 · strength 0.06
- Vincenzo Mazzaferro · 1 shared paper, 2019 · strength 0.06
- Thilo Hackert · 1 shared paper, 2019 · strength 0.06
- Péter Jenő Hegyi · 1 shared paper, 2019 · strength 0.06
- Claus Wilki Fristrup · 1 shared paper, 2019 · strength 0.06
- Gábor Lakatos · 1 shared paper, 2019 · strength 0.06
- Núria Malats · 1 shared paper, 2019 · strength 0.06
- Alfredo Carrato · 1 shared paper, 2019 · strength 0.06
- Michael Bau Mortensen · 1 shared paper, 2019 · strength 0.06
- Francisco X. Real · 1 shared paper, 2019 · strength 0.06
- Eunice Sirri · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.